Align Technology, Inc. (ALGN)
USD 144.32
(-5.89%)
USD 144.32
(-5.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.45 Billion USD | 4.55% |
| 2022 | 2.34 Billion USD | 1.17% |
| 2021 | 2.31 Billion USD | 45.34% |
| 2020 | 1.59 Billion USD | 38.22% |
| 2019 | 1.15 Billion USD | 44.39% |
| 2018 | 799.56 Million USD | 27.42% |
| 2017 | 627.48 Million USD | 56.57% |
| 2016 | 400.76 Million USD | 28.98% |
| 2015 | 310.7 Million USD | 32.09% |
| 2014 | 235.22 Million USD | 18.69% |
| 2013 | 198.17 Million USD | 13.25% |
| 2012 | 174.99 Million USD | 10.42% |
| 2011 | 158.48 Million USD | 59.77% |
| 2010 | 99.19 Million USD | 20.67% |
| 2009 | 82.2 Million USD | 35.2% |
| 2008 | 60.8 Million USD | -1.31% |
| 2007 | 61.6 Million USD | -9.4% |
| 2006 | 68 Million USD | 39.71% |
| 2005 | 48.67 Million USD | 8.22% |
| 2004 | 44.97 Million USD | 14.65% |
| 2003 | 39.22 Million USD | 76.41% |
| 2002 | 22.23 Million USD | 18.18% |
| 2001 | 18.81 Million USD | -87.88% |
| 2000 | 155.23 Million USD | 325.24% |
| 1999 | 36.5 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.4 Billion USD | 0.19% |
| 2024 Q3 | 2.42 Billion USD | 0.88% |
| 2024 Q1 | 2.39 Billion USD | -2.34% |
| 2023 Q1 | 2.42 Billion USD | 3.19% |
| 2023 FY | 2.45 Billion USD | 4.55% |
| 2023 Q4 | 2.45 Billion USD | -2.52% |
| 2023 Q2 | 2.5 Billion USD | 3.5% |
| 2023 Q3 | 2.51 Billion USD | 0.42% |
| 2022 Q3 | 2.21 Billion USD | 0.32% |
| 2022 Q4 | 2.34 Billion USD | 5.79% |
| 2022 FY | 2.34 Billion USD | 1.17% |
| 2022 Q1 | 2.27 Billion USD | -1.85% |
| 2022 Q2 | 2.21 Billion USD | -2.88% |
| 2021 Q3 | 2.13 Billion USD | 6.08% |
| 2021 Q4 | 2.31 Billion USD | 8.72% |
| 2021 FY | 2.31 Billion USD | 45.34% |
| 2021 Q2 | 2.01 Billion USD | 19.98% |
| 2021 Q1 | 1.67 Billion USD | 5.04% |
| 2020 Q4 | 1.59 Billion USD | 15.5% |
| 2020 FY | 1.59 Billion USD | 38.22% |
| 2020 Q1 | 1.11 Billion USD | -3.7% |
| 2020 Q2 | 1.18 Billion USD | 6.2% |
| 2020 Q3 | 1.38 Billion USD | 17.01% |
| 2019 Q1 | 978.72 Million USD | 22.41% |
| 2019 FY | 1.15 Billion USD | 44.39% |
| 2019 Q4 | 1.15 Billion USD | 10.5% |
| 2019 Q3 | 1.04 Billion USD | 7.46% |
| 2019 Q2 | 972.33 Million USD | -0.65% |
| 2018 Q3 | 735.42 Million USD | 5.42% |
| 2018 FY | 799.56 Million USD | 27.42% |
| 2018 Q2 | 697.63 Million USD | 6.46% |
| 2018 Q1 | 655.27 Million USD | 4.43% |
| 2018 Q4 | 799.56 Million USD | 8.72% |
| 2017 Q1 | 414.41 Million USD | 3.41% |
| 2017 Q2 | 472.89 Million USD | 14.11% |
| 2017 Q4 | 627.48 Million USD | 21.68% |
| 2017 Q3 | 515.66 Million USD | 9.04% |
| 2017 FY | 627.48 Million USD | 56.57% |
| 2016 Q3 | 386.58 Million USD | 13.23% |
| 2016 FY | 400.76 Million USD | 28.98% |
| 2016 Q2 | 341.41 Million USD | 8.2% |
| 2016 Q4 | 400.76 Million USD | 3.67% |
| 2016 Q1 | 315.53 Million USD | 1.55% |
| 2015 FY | 310.7 Million USD | 32.09% |
| 2015 Q1 | 234.87 Million USD | -0.15% |
| 2015 Q2 | 258.78 Million USD | 10.18% |
| 2015 Q3 | 281.3 Million USD | 8.7% |
| 2015 Q4 | 310.7 Million USD | 10.45% |
| 2014 Q2 | 209.63 Million USD | 10.98% |
| 2014 Q3 | 225.83 Million USD | 7.73% |
| 2014 Q4 | 235.22 Million USD | 4.16% |
| 2014 FY | 235.22 Million USD | 18.69% |
| 2014 Q1 | 188.88 Million USD | -4.69% |
| 2013 Q2 | 183.69 Million USD | 11.25% |
| 2013 Q3 | 183.52 Million USD | -0.09% |
| 2013 Q4 | 198.17 Million USD | 7.99% |
| 2013 FY | 198.17 Million USD | 13.25% |
| 2013 Q1 | 165.12 Million USD | -5.64% |
| 2012 Q2 | 157.86 Million USD | 7.09% |
| 2012 Q1 | 147.41 Million USD | -6.98% |
| 2012 Q4 | 174.99 Million USD | 5.42% |
| 2012 FY | 174.99 Million USD | 10.42% |
| 2012 Q3 | 165.99 Million USD | 5.15% |
| 2011 Q2 | 117.26 Million USD | 23.6% |
| 2011 FY | 158.48 Million USD | 59.77% |
| 2011 Q3 | 129.04 Million USD | 10.04% |
| 2011 Q4 | 158.48 Million USD | 22.81% |
| 2011 Q1 | 94.87 Million USD | -4.35% |
| 2010 FY | 99.19 Million USD | 20.67% |
| 2010 Q4 | 99.19 Million USD | 15.57% |
| 2010 Q1 | 77.19 Million USD | -6.09% |
| 2010 Q3 | 85.83 Million USD | 14.84% |
| 2010 Q2 | 74.73 Million USD | -3.18% |
| 2009 Q3 | 73.1 Million USD | 4.41% |
| 2009 Q2 | 70.01 Million USD | 13.7% |
| 2009 Q1 | 61.57 Million USD | 1.28% |
| 2009 FY | 82.2 Million USD | 35.2% |
| 2009 Q4 | 82.2 Million USD | 12.45% |
| 2008 Q1 | 54.11 Million USD | -12.16% |
| 2008 Q3 | 56.86 Million USD | -1.87% |
| 2008 Q2 | 57.95 Million USD | 7.08% |
| 2008 FY | 60.8 Million USD | -1.31% |
| 2008 Q4 | 60.8 Million USD | 6.92% |
| 2007 Q3 | 56.18 Million USD | 4.0% |
| 2007 Q4 | 61.6 Million USD | 9.65% |
| 2007 Q1 | 58.05 Million USD | -14.63% |
| 2007 Q2 | 54.02 Million USD | -6.94% |
| 2007 FY | 61.6 Million USD | -9.4% |
| 2006 Q1 | 48.81 Million USD | 0.29% |
| 2006 Q3 | 66.46 Million USD | 47.57% |
| 2006 Q2 | 45.04 Million USD | -7.72% |
| 2006 Q4 | 68 Million USD | 2.31% |
| 2006 FY | 68 Million USD | 39.71% |
| 2005 Q4 | 48.67 Million USD | -7.64% |
| 2005 FY | 48.67 Million USD | 8.22% |
| 2005 Q1 | 45.96 Million USD | 2.21% |
| 2005 Q2 | 53.36 Million USD | 16.1% |
| 2005 Q3 | 52.69 Million USD | -1.25% |
| 2004 FY | 44.97 Million USD | 14.65% |
| 2004 Q1 | 34.93 Million USD | -10.95% |
| 2004 Q2 | 38.78 Million USD | 11.04% |
| 2004 Q3 | 41.79 Million USD | 7.74% |
| 2004 Q4 | 44.97 Million USD | 7.62% |
| 2003 Q4 | 39.22 Million USD | 3.87% |
| 2003 Q1 | 23.24 Million USD | 4.56% |
| 2003 Q2 | 36.03 Million USD | 54.98% |
| 2003 Q3 | 37.76 Million USD | 4.81% |
| 2003 FY | 39.22 Million USD | 76.41% |
| 2002 Q1 | 17.41 Million USD | -7.45% |
| 2002 Q4 | 22.23 Million USD | 36.43% |
| 2002 Q3 | 16.29 Million USD | -9.83% |
| 2002 Q2 | 18.07 Million USD | 3.79% |
| 2002 FY | 22.23 Million USD | 18.18% |
| 2001 Q2 | 16.8 Million USD | -29.58% |
| 2001 Q3 | 16.12 Million USD | -4.08% |
| 2001 Q4 | 18.81 Million USD | 16.72% |
| 2001 FY | 18.81 Million USD | -87.88% |
| 2001 Q1 | 23.86 Million USD | 0.0% |
| 2000 FY | 155.23 Million USD | 325.24% |
| 1999 FY | 36.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Envoy Medical, Inc. | 9.4 Million USD | -25994.32% |
| OrthoPediatrics Corp. | 72.56 Million USD | -3281.139% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -8193.797% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -10505.118% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -576786.341% |
| PAVmed Inc | 57.13 Million USD | -4193.869% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -4686.725% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -9535.11% |
| RxSight, Inc. | 22.18 Million USD | -10957.274% |
| Sight Sciences, Inc. | 46.43 Million USD | -5183.375% |
| SI-BONE, Inc. | 61.05 Million USD | -3918.654% |
| TELA Bio, Inc. | 59.16 Million USD | -4046.548% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -2052.68% |
| Bioventus Inc. | 589.79 Million USD | -315.975% |
| BrainsWay Ltd. | 15.31 Million USD | -15920.556% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -23675.443% |
| CVRx, Inc. | 39.28 Million USD | -6145.578% |
| electroCore, Inc. | 8.94 Million USD | -27327.479% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -45826.395% |
| Inogen, Inc. | 121.38 Million USD | -1921.212% |
| IceCure Medical Ltd | 4.24 Million USD | -57667.554% |
| Spectral AI, Inc. | 12.4 Million USD | -19683.792% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -77003.455% |
| MaxCyte, Inc. | 36.1 Million USD | -6694.771% |
| Acutus Medical, Inc. | 54.83 Million USD | -4373.801% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -100891.561% |
| Talis Biomedical Corporation | 29.22 Million USD | -8295.114% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -132665.557% |
| Orthofix Medical Inc. | 326.58 Million USD | -651.225% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -20416.575% |
| Cerus Corporation | 144.3 Million USD | -1600.152% |
| Venus Concept Inc. | 107.1 Million USD | -2190.681% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -4648.83% |
| LivaNova PLC | 1.15 Billion USD | -112.98% |
| 908 Devices Inc. | 37.49 Million USD | -6444.113% |
| Alphatec Holdings, Inc. | 703.48 Million USD | -248.746% |
| Nemaura Medical Inc. | 26.37 Million USD | -9201.088% |
| NeuroPace, Inc. | 86.99 Million USD | -2720.083% |
| LENSAR, Inc. | 22.4 Million USD | -10848.226% |
| Apyx Medical Corporation | 52.31 Million USD | -4589.377% |
| Cutera, Inc. | 518.12 Million USD | -373.516% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -8265.344% |
| BioSig Technologies, Inc. | 4.68 Million USD | -52266.873% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -4103.382% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -11317.48% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | -11.817% |
| Axonics, Inc. | 82.35 Million USD | -2878.895% |
| Outset Medical, Inc. | 190.91 Million USD | -1185.068% |
| IRIDEX Corporation | 24.91 Million USD | -9747.427% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -1879.097% |
| IRadimed Corporation | 20.73 Million USD | -11731.577% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -146458.423% |
| INVO Bioscience, Inc. | 19.99 Million USD | -12170.031% |
| Telesis Bio, Inc. | 40.87 Million USD | -5902.466% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -5914.646% |
| Varex Imaging Corporation | 668.6 Million USD | -266.944% |
| Quipt Home Medical Corp. | 136.29 Million USD | -1700.084% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -68583.875% |
| Pulmonx Corporation | 60.63 Million USD | -3946.091% |
| Dynatronics Corporation | 11.78 Million USD | -20726.52% |
| Modular Medical, Inc. | 2.27 Million USD | -107883.627% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -60268.799% |
| Semler Scientific, Inc. | 6.27 Million USD | -39028.995% |
| InMode Ltd. | 75.91 Million USD | -3131.799% |
| Bruker Corporation | 2.83 Billion USD | 13.51% |
| Cytosorbents Corporation | 29.98 Million USD | -8081.923% |
| DexCom, Inc. | 4.19 Billion USD | 41.529% |
| Viveve Medical, Inc. | 10.84 Million USD | -22518.125% |
| ZimVie Inc. | 795.85 Million USD | -208.272% |
| Movano Inc. | 5.97 Million USD | -40981.514% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -2245.383% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -576786.341% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -20416.575% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | -283.926% |
| Profound Medical Corp. | 12.66 Million USD | -19270.08% |
| Insulet Corporation | 1.85 Billion USD | -32.222% |
| enVVeno Medical Corporation | 2.43 Million USD | -100655.154% |
| Surmodics, Inc. | 65.82 Million USD | -3627.25% |
| iCAD, Inc. | 8 Million USD | -30563.521% |
| Nuwellis, Inc. | 6.78 Million USD | -36085.664% |
| Biotricity, Inc. | 35.91 Million USD | -6730.251% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -999.942% |
| Aethlon Medical, Inc. | 2.47 Million USD | -98840.899% |
| InspireMD, Inc. | 8.14 Million USD | -30032.502% |
| PAVmed Inc. | 57.13 Million USD | -4193.869% |
| BIOLASE, Inc. | 35.34 Million USD | -6840.67% |
| Beyond Air, Inc. | 29.77 Million USD | -8139.758% |
| FONAR Corporation | 57.45 Million USD | -4169.912% |
| AxoGen, Inc. | 101.16 Million USD | -2325.207% |
| Vivani Medical, Inc. | 25.03 Million USD | -9699.441% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -2694.419% |
| Inari Medical, Inc. | 209.32 Million USD | -1072.047% |
| UFP Technologies, Inc. | 118.04 Million USD | -1978.35% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -19232.486% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -112141.492% |
| Tenon Medical, Inc. | 5.56 Million USD | -43970.199% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -137808.263% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -13812.737% |
| AdaptHealth Corp. | 3.15 Billion USD | 22.193% |
| Sintx Technologies, Inc. | 6.59 Million USD | -37112.013% |
| NanoVibronix, Inc. | 2.68 Million USD | -91239.836% |
| Quanterix Corporation | 78.08 Million USD | -3041.986% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -68583.875% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -50122.886% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | -134.839% |
| TransMedics Group, Inc. | 568.84 Million USD | -331.293% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -14606.798% |
| NeuroMetrix, Inc. | 1.33 Million USD | -183932.993% |
| Hyperfine, Inc. | 9.8 Million USD | -24934.571% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -880.39% |
| Biomerica, Inc. | 2.66 Million USD | -92028.727% |
| Bone Biologics Corporation | 831.4 Thousand USD | -294990.462% |
| AVITA Medical, Inc. | 19.86 Million USD | -12250.054% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -124205.068% |
| Silk Road Medical, Inc | 114.15 Million USD | -2049.116% |